Back to
MORGAN STANLEY
MRNS4 quarters
Position history for
MORGAN STANLEY's holdings in MARINUS PHARMACEUTICALS INC
As of its Q4 2024 13F, Morgan Stanley held 3,299,229 shares of MRNS (Marinus Pharmaceuticals), worth $1.8M. Morgan Stanley's 13F filings listed MRNS from Q2 2024 to Q4 2024, 3 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$210,381
Total Shares Change
-179,812
Quarter-by-Quarter History
Other major holders of MRNS: Avoro Capital Advisors LLC, BlackRock Finance, Inc., FRANKLIN TEMPLETON INC